PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 32 filers reported holding PROTARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $944 | -29.9% | 565 | +0.4% | 0.00% | – |
| Q2 2023 | $1,346 | -23.2% | 563 | +0.5% | 0.00% | – |
| Q1 2023 | $1,753 | +17.0% | 560 | +0.2% | 0.00% | – |
| Q4 2022 | $1,498 | +49.8% | 559 | +0.2% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 558 | -1.4% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 566 | +1.1% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 560 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 560 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -50.0% | 560 | +0.2% | 0.00% | – |
| Q2 2021 | $6,000 | -99.4% | 559 | -99.2% | 0.00% | – |
| Q1 2021 | $1,075,000 | +239.1% | 68,292 | +420.9% | 0.00% | – |
| Q4 2020 | $317,000 | +13.6% | 13,110 | -20.8% | 0.00% | – |
| Q3 2020 | $279,000 | +8.6% | 16,563 | +89.0% | 0.00% | – |
| Q2 2020 | $257,000 | – | 8,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
| Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
| Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
| Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
| Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
| Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
| OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |